Female embryonic lethality in mice nullizygous for both Msh2 and p53
Authors:
- 1 September 1997
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 17 (1) , 114-118
Abstract
The mutator hypothesis of tumorigenesis suggests that loss of chromosomal stability or maintenance functions results in elevated mutation rates, leading to the accumulation of the numerous mutations required for multistep carcinogenesis1. The human DNA mismatch repair (MMR) genes are highly conserved homologues of the Escherichia coli MutHLS system, which contribute to genomic stability by surveillance and repair of replication misincorporation errors and exogenous DNA damage2. Mutations in one of these MMR genes, HMSH2, account for about half of all cases of genetically linked hereditary non-polyposis colorectal cancer3,4. Loss of function of p53 has also been proposed to increase cellular hypermutability, thereby accelerating carcinogenesis5, although a clear role for p53 in genomic instability remains controversial2. p53 is mutated frequently in a wide range of human cancers, including colonic tumours6. Both Msh2- and p53-targeted knockout mice are viable and susceptible to cancer7–11. Here we demonstrate that combined Msh2 and p53 ablation (Msh2−/−p53−/−) results in developmental arrest of all female embryos at 9.5 days. In contrast, male Msh2−/−p53−/− mice are viable, but succumb to tumours significantly earlier (t1/2 is 73 days) than either Msh2−/− or p53−/− littermates. Furthermore, the frequency of microsatellite instability (MSI) in tumours from Msh2−/−p53−/− mice is not significantly different than in Msh2−/− mice. Synergism in tumorigenesis and independent segregation of the MSI phenotype suggest that Msh2 and p53 are not genetically epistatic.Keywords
This publication has 22 references indexed in Scilit:
- Mutations in the p53 and SCID genes cooperate in tumorigenesis.Genes & Development, 1996
- MSH2 deficient mice are viable and susceptible to lymphoid tumoursNature Genetics, 1995
- Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancerCell, 1995
- Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability.Genes & Development, 1995
- X chromosome inactivation and the Xist geneCurrent Opinion in Genetics & Development, 1994
- Tumor spectrum analysis in p53-mutant miceCurrent Biology, 1994
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- A genetic model for colorectal tumorigenesisCell, 1990
- Differentiation of X chromosomes in early female mouse embryosExperimental Cell Research, 1974
- Asynchronous Duplication of Chromosomes in Cultured Cells of Chinese HamsterJournal of Cell Biology, 1960